Organon Profit Margin

The latest profit margin for OGN is 2.21% as of June 2026. That compares with 11.84% in the prior-year period — down 81.3% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Organon's historical trend and sector peers before judging valuation or financial health.

Over the past year, OGN's profit margin moved from 11.84% to 2.21% — a 81.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Organon's valuation or profitability profile.

Against Healthcare companies, OGN currently prints 2.21% for profit margin, while the sector average sits near 21.34%. That is roughly 89.6% below the sector mean. Large gaps often invite a closer look at Organon's growth, margins, and balance sheet.

Profit Margin shows how effectively Organon converts resources into returns. At 2.21%, OGN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 11.84% in the prior-year period — down 81.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OGN's profit margin (2.21%), review year-over-year change from 11.84%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.